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Abstract: Simultaneous kidney-pancreas
transplantation (SKPtx) is an established
procedure at many transplant centres for the
treatment of end-stage renal disease from
type I diabetes mellitus.

Guy’s & St Thomas Hospital
Transplantation Department
London -United Kingdom

A successful transplant normalises glucose
metabolism and may prevent or reverse some
of the complications of diabetes. Concerning
graft survival and morbidity rates, the
usefulness of this procedure is still questioned
by some authors (1,2). We undertook a
retrospective study to investigate the
differences between survival rates of SKPtx
and kidney alone transplant (Ktx)

Introduction
SKPtx is currently the only known treatment
procedure capable of establishing an insulin-free
euglycaemic state with complete normalisation of
glycohaemoglobin levels in type I diabetic nephropathy
patients (5). The success rate of SKPtx has dramatically
improved over the last decade. According to registry data,
patient and kidney/pancreas graft survival rates were
92%, 86% and 78% at 1 year respectively (6). Although
short-term results are promising, with the need for more
potent immunosuppression and due to increased risk of
surgical complications there is still controversy concerning
graft and patient survival in SKPtx.

Materials and Methods
We retrospectively reviewed the records of 64
technically successful SKPtx operations performed
between April 1996 and September 2000 in our
department, and compared 12 and 36 month survival
rates with the same number of cadaveric diabetic Ktx
recipients. In the SKPtx group there were 35 females and
29 males with a mean age of 38 years. All patients
received a kidney and pancreas from the same cadaveric
donor. A careful pretransplant evaluation was performed

recipients.We also evaluated morbidity rates
and complications in both groups. There were
no significant differences in 12 and 36 month
survival rates. Due to the exocrine bladder
drainage technique, urologic complications
constitute a major part of morbidity after
SKPtx (3,4) (87%), but these problems are
usually treated conservatively. We conclude
that SKPtx is a safe and effective method
resulting in complete freedom from
exogenous insulin, dialysis and strict dietary
control.
Key Words: Simultaneous kidney-pancreas
transplantation, Type I diabetic nephropathy

in order to exclude patients with severe vascular and
cardiac complications. The retrieval of pancreas and
kidney was always from a multiorgan procurement using
a standard surgical technique and preservation with
Eurocollins solution. In all cases arterial reconstruction of
the pancreas was performed with a donor iliac Y-graft. All
patients received a whole pancreatic graft using the
bladder drainage technique and they were also treated
with a standard quadruple immunosuppressive regimen
(antithymocyte globulin Merieux for 15 days posttransplant; cyclosporine introduced at day 0; steroids;
and azathioprine introduced at day 45 post-transplant).
No perfect HLA matching criteria were used to allocate
the organs. Anti-cytomegalovirus prophylaxis with
acylovir was routinely given and pancreas rejection was
diagnosed when urinary amylase decreased more then
50% following confirmation on admision. In the Ktx
group there were 39 males and 25 females with a mean
age of 36 years. Immunosuppression consisted of
cyclosporine A and steroids. Kidney rejection was
considered for any increase in serum creatinine that was
unresponsive to a decrease in the cyclosporine dose. A
core needle biopsy was obtained in all cases to confirm
histologically the clinical diagnosis of rejection. All data
are expressed as mean ± standard deviation or as
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percentages. Characteristics of patients in the two study
groups were compared by paired t-test.

Results
Pre-transplant characteristic of patients in the Ktx and
SKPtx groups are shown in Table 1. Compared with
cadaveric diabetic Ktx recipents, SKPtx recipents had
significantly fewer HLA matches and more HLA
mismatches with their donors. There were no significant
differences between 12 and 36 month survival rates of
the SKPtx and Ktx groups (Table 2). Although rejection
episodes are more common in the SKPtx group (75%, n
= 48 versus 60%, n = 38), renal allograft survival rates
were also similar. In SKPtx recipients, 7 pancreas grafts
were lost. Three were lost as a result of early venous
thrombosis, 2 irreversible rejection and 2 deaths with
functioning graft. Six kidney losses were recorded. Three
were a result of irreversible rejection, 1 multiorgan
failure after thrombosis of the pancreas graft and 2
Table 1.

Pretransplant characteristics of kidney alone transplants
(Ktx) (n = 64) and simultaneous kidney-pancreas transplant
(SKPtx) (n = 64) recipients.

Age

Ktx

SKPtx

P

38.1 ± 7.1

36.0 ± 7.4

0.19

HLA match (A,B,DR)

2.4 ± 1.8

1.3 ± 1.3

< 0.001

HLA mismatch

3.2 ± 1.8

4.3 + 1.3

< 0.001

deaths with a functioning graft. During follow up there
were no significant differences between the mean
creatinine concentrations of the two groups (Table 3).
Blood sugar levels fell from a mean of 191 –mg/dl preSKPtx to 92-mg/dl post-SKPtx and remained stable.
Glycohaemoglobin levels were normal, ranging from a
mean of 4.1% at month 12 to 5.7 % at month 36. Nine
patiets died in both groups (Table 4). The most
frequently observed comlication in SKPtx were recurrent
urinary tract infections ( 84%) and dysuria (36%) due to
pancreatic amylase irritation. In 2 patients recurrent
episodes of graft pancreatisis persisted with pseudocyst
formation and one of them was drained surgically
because of superinfection.

Discussion
The results of our study suggest that renal allograft
survival are comparable in diabetic patients receiving
either Ktx or SKPtx. The recipients of combined kidneypancreas transplants are rare because they receive two
organs from the same donor simultaneously. This makes
it diffucult to determine the cause of graft loss as well as
complicating the allograft survival after SKPtx. The
pancreas transplant registry includes data on technically
unsuccessful pancreas allografts, which results in inferior
SKPtx survival compared with the Ktx allograft (7,8). Our
opinion is that large single-centre series provide more
realistic results than the registry. Our results confirm
those of other centres which have reported higher rates
Table 2.

SKPtx (n = 64)

Ktx (n = 64)

12 month and 36 month patient survival (%)

98/92

92/85

12 month and 36 month kidney survival (%)

92/85

87/79

12 month and 36 month pancreas survival (%)

82/77

_

75

60

Incidence of at least one renal rejection (%)

Table 3.

Simultaneous
kidney-pancreas
transplants (SKPtx) versus kidneyalone transplants (Ktx).

Serum creatinine concentrations (mg/dl) after kidney alone transplants (Ktx) or simultaneous kidney-pancreas transplants (SKPtx).

Post-transplant months

1

3

6

12

18

24

36

SKPtx

2.2±0.8

1.8±0.5

1.9±0.6

2.0±0.7

2.2±1.1

2.3±1.4

2.7±1.8

Ktx

2.1±0.6

1.8±0.6

1.7±0.7

1.9±0.9

2.0±1.2

2.1±1.9

2.2±1.6

0.66

0.61

0.55

0.30

0.28

0.39

0.17

P
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Table 4.

Causes of death in patients in simultaneous kidney
pancreas transplants (SKPtx) and kidney-alone transplant
(Ktx) series.

Recipients
1. SKPtx
Myocardial infarction
Sudden cardiac arrest
Sepsis
Lymphoma
2.

Ktx
Sudden cardiac arrest
Myocardial infarction
Pneumonia

n
2
2
1
1

1
1
1

provide a normal beta cell mass and presumably normally
functioning beta cells. The potential effect of poorer HLA
matching and higher rates of renal allograft rejection are
balanced by the beneficial effects of euglyceamia in
preventing recurrent diabetic nephropathy and positively
affects the evolution of neuropathy (12,!3). On the other
hand, retinopathy, and micro- macro-angiopathy do not
clearly benefit from the transplanted pancreas (14).
Higher costs and higher morbidity are the counterpart of
this success. Finally, our preliminary results showed that
SKPtx is a safe and effective method to treat Type I
diabetic nephropathy.

Correspondence author:

of renal allograft rejection in SKPtx recipients compared
to Ktx recipients (9,10). Our data are parallel to those of
Douzdjian et al., who reported lesser degrees of HLA
matching in SKPtx recipients (11). Pancreas transplants
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